# FDA Inspection 1249620 - Fayz A. Hudefi, M.D. - September 20, 2024

Source: https://www.keypedia.com/records/fda_inspections/fayz-a-hudefi-md/90a08b74-1c3e-4b32-a605-553dc5b98901
Source feed: FDA_Inspections

> FDA inspection 1249620 of Fayz A. Hudefi, M.D., September 20, 2024. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 312. Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1249620
- Company Name: Fayz A. Hudefi, M.D.
- Inspection Date: 2024-09-20
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring: Human Drugs
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Dallas District Office
- Citation Count: 1

## Related Documents

- [FDA Inspection 1204113 - 2023-04-21](https://www.keypedia.com/records/fda_inspections/fayz-a-hudefi-md/0f9eb30e-0a46-4173-afa9-296053a02d79)
- FDA Inspection 1131413 - 2020-09-16

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/audrey-j-yarbrough/1bab3d1a-3246-451e-96fb-4ce52185e850)

Company: https://www.keypedia.com/companies/fayz-a-hudefi-md/01861255-1c5d-4ec4-9bf9-f60e5ecfe54d

Office: https://www.keypedia.com/offices/dallas-district-office/2d1ee9ae-c44c-4494-8186-a920a69b98f9